DRUG-INDUCED ACUTE-PANCREATITIS - FURTHER CRITICISM

被引:48
作者
FRICK, TW
SPEISER, DE
BIMMLER, D
LARGIADER, F
机构
[1] Department of Surgery and Pathology, University Hospital, Zürich
关键词
ACUTE PANCREATITIS; CHEMICALLY INDUCED PANCREATITIS; DRUG-INDUCED PANCREATITIS; ETIOLOGY OF PANCREATITIS;
D O I
10.1159/000171405
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A comprehensive literature search was performed to collect all available data on drug-induced pancreatitis. Strong evidence for an association with acute pancreatitis has been described for anticholinesterases, calcium 2',3'-dideoxyinosine, estrogen, L-asparaginase, salicylates, thiazide-diuretics, valproic acid, and vinca alkaloids. Weak evidence has been found for antituberculous agents, azathioprine, biguanides, cisplatinum, cyclosporine A, H-2-blocking agents, loop diuretics, 6-mercaptopurine, metronidazole, pentamidine, steroids, sulfonamides, sulindac and tetracycline. Many cases were associated with underlying conditions known to induce acute pancreatitis themselves. It is concluded that for none of the drugs studied the available data are consistent enough to support a definite association with acute pancreatitis. Nevertheless, the data suggest that drugs may be a trigger or a cofactor in inducing pancreatitis.
引用
收藏
页码:113 / 132
页数:20
相关论文
共 219 条
[51]  
Pratt C.B., Simone J.V., Zee P., Aur R.J., Johnson W.W., Comprison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia, J Pediatr, 77, pp. 474-483, (1970)
[52]  
Tan C.L., Chang S.P., Week K.P., Acute hemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukemia-A case report, Singapore Med J, 15, pp. 278-282, (1974)
[53]  
Shaw M.T., Barnes C.C., Madden F.J.F., Bagshawe K.D., L-Asparaginase and pancreatitis, Lancet, 2, (1970)
[54]  
McLean R., Martin S., Lam-Po-Tang P.R.L., Fatal case of L-asparaginase induced pancreatitis, Lancet, 2, pp. 1401-1402, (1982)
[55]  
Jain R., Ramanan S.V., Iatrogenic pancreatitis. A fatal complication in the induction therapy for acute lymphocytic leukemia, Arch Intern Med, 138, (1978)
[56]  
Greenstein R., Nogeire C., Ohnuma T., Greenstein A., Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst, Cancer, 43, pp. 718-722, (1979)
[57]  
Halskell C.M., Cancllos G.P., Levcn-Thal B.G., Carbone P.P., Block J.B., Ser-Pick A.A., Selawry OS: L-Asparaginase-therapeutic and toxic effects in patients with neoplastic disease, N Engl J Med, 281, pp. 1028-1034, (1969)
[58]  
Oetlgen H.F., Stephenson P.A., Schwartz M.K., Leeper R.D., Tallal L., Tan C.C., Clarkson B.D., Golbey R.B., Krakoff I.H., Kamofsky D.A., Murphy M.L., Burchcnal J.H., Toxicity of E. coli L-asparaginase in man, Cancer, 25, pp. 253-278, (1970)
[59]  
Zubrod C.G., The clinical toxicities of L-asparaginase, Pediatrics, 45, pp. 555-558, (1970)
[60]  
Whitecar J.P., Bodey G.P., Harris J.E., Freireich E.J., Current concepts: L-Asparaginasc, N Engl J Med, 282, pp. 732-734, (1970)